Cargando…
Clinical Trials in Oncology and Defining Benefit
In response to the recently published article by Goldberg et al., which discusses changing aspects of clinical trial design in oncology, this letter to the editor elaborates on the definitions of benefits, efficacy, and futility.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AlphaMed Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759827/ https://www.ncbi.nlm.nih.gov/pubmed/29133517 http://dx.doi.org/10.1634/theoncologist.2017-0476 |
| Sumario: | In response to the recently published article by Goldberg et al., which discusses changing aspects of clinical trial design in oncology, this letter to the editor elaborates on the definitions of benefits, efficacy, and futility. |
|---|